Business Wire

Lightspeed China Partners Closes on $560 Million of Committed Capital

Share

Lightspeed China Partners (LCP) announced that it has completed the final closing of fund family IV with total committed capital of $560 million, including Lightspeed China Partners IV at $360 million and Lightspeed China Partners Select I at $200 million. This is the largest fund family raised by LCP to date and brings committed capital under management to $1.5 billion. LCP IV will make investments in early stage technology companies in China while LCP Select I will focus on growth investments in China.

In the past 18 months, five portfolio companies that LCP invested in at an early stage have completed successful IPOs, including InnoLight (SZ:300308), Meituan Dianping (HK:3690), Pinduoduo (NASDAQ:PDD), PPDai (NYSE:PPDF), and Rong360 (NYSE:JT).

In addition to the publicly traded companies, LCP has nurtured many innovative industry leaders across multiple sectors, including Black Fish, Fan Deng Reading Club, Fangdd, Full Truck Alliance, Hesai, Ifchange, QingCloud, Sunmi, Sweetome, Tencent Trusted Doctors, Tujia, Xiao Peng Auto, and XY Link.

First Institutional Venture Capital with Global Reach

The LCP team serves as lead investors in companies’ first institutional venture capital financings with a focus on Series A and Series B investments in China. The team brings an entrepreneurial perspective as many team members have either been successful entrepreneurs or have served as executives in technology companies. While partnering at the earliest stages of company formation, LCP is committed to financing companies throughout their lifecycles and contributing teambuilding and strategy development capabilities. LCP also provides founders with global aspirations access to an international network through Lightspeed’s global venture capital operations which include over 400 portfolio companies in the U.S., China, India, Southeast Asia, Europe, and Israel. LCP has access to global trends and business model innovation as well as international talent, customers, partners and capital markets. Over more than a decade, LCP has developed a track record of helping China-based companies establish dominant market positions and expand globally.

Early Backers of Emerging Concepts

LCP has been an early investor in China’s consumer Internet, Internet+, and enterprise/deep tech sectors. More than half of the partnership’s investments have been in consumer Internet and Internet+, where technology is applied to create disruptive new business models in traditional industries. Notable areas of investment include social network applications, marketplaces, e-commerce, consumer services as well as enterprise products/services and deep tech. LCP has supported and nurtured an outstanding group of early-stage companies that have become unicorns in areas including new retail, culture, entertainment, travel, finance, real estate, healthcare, education, recruiting, and transportation.

LCP has successfully identified emerging market opportunities and has often served as the first source of capital in areas where there was initially limited institutional interest. A notable example is trucking logistics. Five years ago, LCP was the sole Series A investor in Full Truck Alliance (Yun Man Man) when the founders were exploring using a mobile platform to solve logistics and communications challenges in China’s fragmented trucking industry. After multiple large follow-on rounds where LCP continued to invest, the company merged with Huo Che Bang to form Full Truck Alliance which is now the world’s largest trucking logistics marketplace.

Due to the size of the consumer markets in China and availability of technology talent, China-based Internet and marketplace companies are increasingly becoming world leaders. Herry Han, Founding Partner of LCP, commented: “We believe there are plenty of new opportunities in China consumer Internet given the depth of China’s mobile payment and social networks. Innovation and entrepreneurship in the next decade will bring more China-based startups to the world stage. This will be China’s first decade of truly global innovation. Chinese entrepreneurs are now developing business plans with global expansion in mind from day one. We look forward to meeting entrepreneurs with ambitious visions and supporting them in realizing their dreams.”

LCP was also early to the enterprise and deep tech sectors in China. According to LCP Founding Partner, James Mi: “China’s enterprise service and deep tech innovation is in the early innings of development. Given China’s vast market, deep talent pool, and increasing demand for home-grown deep technologies across various industries, we are seeing accelerated growth and significant investment opportunities. LCP is uniquely positioned to be the leading early stage investor in these areas.” The LCP team has been investing in deep tech and enterprise opportunities from the beginning with multiple public company outcomes.

One of LCP’s deep tech portfolio companies is InnoLight which provides high speed optical transceiver modules for web-scale data centers supporting cloud computing. Customers include Google, Amazon AWS, and AliCloud. LCP invested in InnoLight in 2014, and the company became publicly listed in 2017.

LCP’s enterprise and deep tech investments span autonomous vehicles, AI, IoT, SaaS, enterprise marketplaces, semiconductors, and optical communications. The team will continue to leverage its deep tech industry expertise in support of experienced founders building industry leading companies.

Supportive Culture Underpinning Value Creation

Focus, excellence, mutual respect, and support are among the core values of LCP. The partnership believes that mutual respect and support between investors and entrepreneurs is a cornerstone of effective long-term partnerships. This principle applies equally within the firm. LCP strives to promote positive change and impact to society in the way it conducts its business. The team looks forward to continuing its partnership with game-changing founders and accompanying them from the beginning of their startup journeys through multiple stages of global growth.

About Lightspeed China Partners

Lightspeed China Partners (LCP) is a leading venture capital firm in China focused on early stage investments in consumer Internet, Internet+ and enterprise/deep tech. With strong backgrounds in company operations and entrepreneurship, the partners of LCP are committed to helping a new generation of Chinese entrepreneurs become industry leaders, build world-class companies, and create social impact. Over the past 10 years, the Lightspeed China team has backed industry leading companies including Meituan Dianping, Pinduoduo, Full Truck Alliance, InnoLight, PPDai, Rong360, Tujia and Fangdd. LCP offers international value-added capabilities through its relationship with Lightspeed Venture Partners, a global venture capital firm managing over $6 billion of committed capital.

Contact information

Lightspeed Venture Partners
Rachel Manson
VP, Marketing
703-399-5908
rachel@lsvp.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

EURid Launches New Eligibility Criteria19.10.2019 04:30:00 CESTPress release

The top-level internet domain .eu is the eighth largest country code extension on the internet and, as of October 2019, we have more than 3.6 million registrations spread out across Europe. Since its launch in 2006, only companies and individuals residing within the EU and EEA member states have been eligible to register the .eu domain name. However, striving to meet the needs of an ever-changing digital environment, the eligibility criteria for the registration of .eu domain name has now been extended to all EU citizens living around the world. With millions of Europeans living around the world – our hope is to provide these individuals, living far from their native lands, with a personal online platform through which they can share their stories with families and friends back home. “We are excited to be able to extend the registration criteria to EU citizens around the world. The .eu domain is now closer to your ambitions, achievements and dreams. It is the bridge connecting you to y

ams to Launch New Takeover Offer for OSRAM at EUR 41.00 Per Share With Minimum Acceptance Threshold of 55%18.10.2019 17:16:00 CESTPress release

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, announces that it intends to launch a new all-cash takeover offer for OSRAM Licht AG ("OSRAM") for 100% of the share capital of OSRAM at a price of EUR 41.00 per share ("Offer"). The Offer which represents a premium of 42% to the undisturbed OSRAM share price of EUR 28.92 as of 2 July 2019 will be launched by ams Offer GmbH, a newly incorporated, wholly owned subsidiary of ams. ams is the largest shareholder in OSRAM with a direct shareholding of 19.99% which ams will not exceed outside of the Offer. As a result of ams' shareholder position, ams has lowered the minimum acceptance threshold to 55%. Winning way forward for ams and OSRAM The combination of ams and OSRAM allows ams to create a global leader in sensor solutio

Resecurity Appoints Selene Giupponi Managing Director of Resecurity Europe18.10.2019 15:38:00 CESTPress release

Resecurity, a cybersecurity company that delivers in-depth analysis layered on top of the most comprehensive, exclusive sets of data from the Deep and Dark Web, announces that Selene Giupponi has joined as Managing Director and will be based in Italy. A digital forensics expert, Selene adds significant value to Resecurity’s operations in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191018005415/en/ Resecurity Appoints Selene Giupponi Managing Director of Resecurity Europe (Photo: Business Wire) Selene has extensive expertise in digital forensics and is often called as an expert witness regarding digital and mobile forensics on domestic and international cases, investigations and court trials. She is a specialized IT trainer in Italy and teaches digital, mobile, cloud and mainframe forensics, cybercrime and information security at various Italian universities. “Selene brings a depth of experience to our team and we

Secure-24 Completes Acquisition of Symmetry Corporation18.10.2019 14:20:00 CESTPress release

NTT Ltd., the newly formed, world-leading global technology services provider, and Symmetry Holding Inc. (Symmetry), a U.S.-based leading provider of SAP managed services, today announced that Secure-24 Intermediate Holdings, Inc. (Secure-24), part of the Managed Services division of NTT Ltd., has completed the acquisition of Symmetry Corporation effective October 17, 2019. “The powerful business combination of Secure-24 and Symmetry leverages the strengths of both companies around Secure-24’s foundation of delivering managed IT operations, application hosting and cloud services to enterprises worldwide,” said Mike BeDell, Chief Executive Officer, Secure-24. “As we begin to integrate Symmetry’s portfolio into Secure-24’s portfolio, through a shared vision, we look forward to providing even greater value that accelerates our clients’ business success.” Symmetry, headquartered in Brookfield, Wisconsin, will expand the scale of SAP managed services capabilities of Secure-24 and bring new

New Research Reveals Updated Patient Preferences on Digital Health Technology18.10.2019 13:00:00 CESTPress release

ResMed (NYSE: RMD, ASX: RMD) today announced results from a company-led survey, revealing new patient preferences on digital health technology. The survey highlights a reason for optimism that the markets for digital health technology will only continue to grow. The survey of a nationally representative sample of 3,000 Americans, conducted in partnership with Edelman Intelligence, revealed that the use of – and confidence in – remote digital health technology is widespread: 56% of those surveyed currently monitor their health with at least one digital data collection tool. Also, 60% of people attempt to diagnose themselves after browsing symptoms on the Internet – including 76% of Millennials. Perhaps more surprising, remote digital health technology seems to have deepened people’s connection with their physicians rather than distanced them from one another. Over half of those surveyed agree that technology has improved their relationship with their primary care provider, and many woul

CHMP Grants Positive Opinion for Expanded Use of Janssen’s Darzalex®▼(daratumumab) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible18.10.2019 12:43:00 CESTPress release

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended broadening the existing marketing authorisation for Darzalex® (daratumumab) to include the use of daratumumab in combination with lenalidomide and dexamethasone (DRd) for patients with newly diagnosed multiple myeloma (NDMM) who are ineligible for autologous stem cell transplant (ASCT). “As multiple myeloma can become more complex with each relapse, it is important that patients receive the latest treatment options with the goal of extending their first remission period,” said Professor Thierry Facon, M.D., Service des Maladies du Sang, Hôpital Claude Huriez, Lille, France, and principal investigator of the MAIA study. “For newly diagnosed patients who are transplant ineligible, this regimen could be an important frontline therapy option and reinforces the consistent clinical profile of daratumuma